Technology
Health
Medical

PerkinElmer

$95.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.07%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PerkinElmer and other stocks, options, ETFs, and crypto commission-free!

About

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. Read More The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Employees
12,500
Headquarters
Waltham, Massachusetts
Founded
1937
Market Cap
10.52B
Price-Earnings Ratio
44.42
Dividend Yield
0.36
Average Volume
626.65K
High Today
$95.90
Low Today
$94.14
Open Price
$95.42
Volume
145.21K
52 Week High
$98.33
52 Week Low
$70.83

Collections

Technology
Health
Medical
Food
Software Service
US
North America

News

TradingNewsNowMar 19

Stock to Watch: PerkinElmer (NYSE: PKI)

PerkinElmer is in the medical diagnostics and research industry and is part of the healthcare sector. The company CEO is Robert F. Friel. PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics. Previous Intraday Trading Performance: The PKI stock showed a previous change of -0.01% with an open at 94.40 and a close of 94.03. ...

6
Simply Wall StMar 11

Does PerkinElmer, Inc.’s (NYSE:PKI) CEO Salary Reflect Performance?

Rob Friel has been the CEO of PerkinElmer, Inc. (NYSE:PKI) since 2008. First, this article will compare CEO compensation with compensation at other large companies. After that, we will consider the growth in the business. Third, we’ll reflect on the total return to shareholders over three years, as a second measure of business performance. This process should give us an idea about how appropriately the CEO is paid. See our latest analysis for PerkinElmer How Does Rob Friel’s Compensation Compare With Simi...

7
TradingNewsNowMar 4

Current Fundamentals: PerkinElmer (NYSE: PKI)

PerkinElmer is part of the healthcare sector and is in the medical diagnostics and research industry. The company CEO is Robert F. Friel. PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics. Previous Intraday Trading Performance: The PKI stock showed a previous change of -0.77% with an open at 97.27 and a close of 95.72. ...

8

Earnings

$0.61
$0.80
$0.99
$1.18
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.